• 1
    Epstein M. Resistant hypertension: prevalence and evolving concepts. J Clin Hypertens (Greenwich). 2007;9(1 suppl 1):26.
  • 2
    Park J, Campese V. Clinical characteristics of resistant hypertension: the importance of compliance and the role of diagnostic evaluation in delineating pathogenesis. J Clin Hypertens (Greenwich). 2007;9(1 suppl 1):712.
  • 3
    Cushman WC, Ford CE, Cutler JA, et al. Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens (Greenwich). 2002;4:393404.
  • 4
    Bortolotto LA, Hanon O, Franconi G, et al. The aging process modifies the distensibility of elastic but not muscular arteries. Hypertension. 1999;34(4 pt 2):889892.
  • 5
    Zieman SJ, Melenovsky V, Kass DA. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol. 2005;25:932943.
  • 6
    Laurent S, Kingwell B, Bank A, et al. Clinical applications of arterial stiffness: therapeutics and pharmacology. Am J Hypertens. 2002;15:453458.
  • 7
    O'Rourke MF, Staessen JA, Vlachopoulos C, et al. Clinical applications of arterial stiffness; definitions and reference values. Am J Hypertens. 2002;15:426444.
  • 8
    Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med. 2001;345:479486.
  • 9
    Lloyd-Jones DM, Evans JC, Larson MG, et al. Differential control of systolic and diastolic blood pressure: factors associated with lack of blood pressure control in the community. Hypertension. 2000;36:594599.
  • 10
    O'Rourke MF. From theory into practice: arterial haemodynamics in clinical hypertension. J Hypertens. 2002;20:19011915.
  • 11
    Hicks LS, Fairchild DG, Horng MS, et al. Determinants of JNC VI guideline adherence, intensity of drug therapy, and blood pressure control by race and ethnicity. Hypertension. 2004;44:429434.
  • 12
    Stockwell DH, Madhavan S, Cohen H, et al. The determinants of hypertension awareness, treatment, and control in an insured population. Am J Public Health. 1994;84:17681774.
  • 13
    Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988–1991. Hypertension. 1995;25:305313.
  • 14
    Waddell TK, Dart AM, Gatzka CD, et al. Women exhibit a greater age-related increase in proximal aortic stiffness than men. J Hypertens. 2001;19:22052212.
  • 15
    Din-Dzietham R, Couper D, Evans G, et al. Arterial stiffness is greater in African Americans than in whites: evidence from the Forsyth County, North Carolina, ARIC cohort. Am J Hypertens. 2004;17:304313.
  • 16
    Berry KL, Cameron JD, Dart AM, et al. Large-artery stiffness contributes to the greater prevalence of systolic hypertension in elderly women. J Am Geriatr Soc. 2004;52:368373.
  • 17
    Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. JAMA. 2003;290:199206.
  • 18
    Kramer H, Han C, Post W, et al. Racial/ethnic differences in hypertension and hypertension treatment and control in the multi-ethnic study of atherosclerosis (MESA). Am J Hypertens. 2004;17:963970.
  • 19
    Chaturvedi N, Bulpitt CJ, Leggetter S, et al. Ethnic differences in vascular stiffness and relations to hypertensive target organ damage. J Hypertens. 2004;22:17311737.
  • 20
    Perregaux D, Chaudhuri A, Rao S, et al. Brachial vascular reactivity in blacks. Hypertension. 2000;36:866871.
  • 21
    Lavie P, Hoffstein V. Sleep apnea syndrome: a possible contributing factor to resistant hypertension. Sleep. 2001;24:721725.
  • 22
    Logan AG, Perlikowski SM, Mente A, et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens. 2001;19:22712277.
  • 23
    Safar ME, Czernichow S, Blacher J. Obesity, arterial stiffness, and cardiovascular risk. J Am Soc Nephrol. 2006;17(4 suppl 2):S109S111.
  • 24
    Sutton-Tyrrell K, Newman A, Simonsick EM, et al. Aortic stiffness is associated with visceral adiposity in older adults enrolled in the study of health, aging, and body composition. Hypertension. 2001;38:429433.
  • 25
    Tsioufis C, Thomopoulos K, Dimitriadis K, et al. The incremental effect of obstructive sleep apnoea syndrome on arterial stiffness in newly diagnosed essential hypertensive subjects. J Hypertens. 2007;25:141146.
  • 26
    Kitahara Y, Hattori N, Yokoyama A, et al. Effect of CPAP on brachial-ankle pulse wave velocity in patients with OSAHS: an open-labelled study. Respir Med. 2006;100:21602169.
  • 27
    Jelic S, Bartels MN, Mateika JH, et al. Arterial stiffness increases during obstructive sleep apneas. Sleep. 2002;25:850855.
  • 28
    Brown MJ, Castaigne A, de Leeuw PW, et al. Influence of diabetes and type of hypertension on response to antihypertensive treatment. Hypertension. 2000;35:10381042.
  • 29
    Tedesco MA, Natale F, Di Salvo G, et al. Effects of coexisting hypertension and type II diabetes mellitus on arterial stiffness. J Hum Hypertens. 2004;18:469473.
  • 30
    Tomiyama H, Hashimoto H, Hirayama Y, et al. Synergistic acceleration of arterial stiffening in the presence of raised blood pressure and raised plasma glucose. Hypertension. 2006;47:180188.
  • 31
    Peralta CA, Hicks LS, Chertow GM, et al. Control of hypertension in adults with chronic kidney disease in the United States. Hypertension. 2005;45:11191124.
  • 32
    Marin R, Fernandez-Vega F, Gorostidi M, et al. Blood pressure control in patients with chronic renal insufficiency in Spain: a cross-sectional study. J Hypertens. 2006;24:395402.
  • 33
    London GM, Blacher J, Pannier B, et al. Arterial wave reflections and survival in end-stage renal failure. Hypertension. 2001;38:434438.
  • 34
    Gosse P, Safar ME. Arterial stiffness and plasma creatinine in untreated hypertensive patients. Am J Hypertens. 2005;18(9 pt 1):11401145.
  • 35
    Safar ME, London GM, Plante GE. Arterial stiffness and kidney function. Hypertension. 2004;43:163168.
  • 36
    Muxfeldt ES, Bloch KV, Nogueira AR, et al. Twenty-four hour ambulatory blood pressure monitoring pattern of resistant hypertension. Blood Press Monit. 2003;8:181185.
  • 37
    Bouthier JD, De Luca N, Safar ME, et al. Cardiac hypertrophy and arterial distensibility in essential hypertension. Am Heart J. 1985;109:13451352.
  • 38
    Lartaud-Idjouadiene I, Lompre AM, Kieffer P, et al. Cardiac consequences of prolonged exposure to an isolated increase in aortic stiffness. Hypertension. 1999;34:6369.
  • 39
    Nichols WW, O'Rourke MF. McDonald's Blood Flow in Arteries. 5th ed. London, England: Hodder Arnold; 2005.
  • 40
    Tanaka H, Dinenno FA, Monahan KD, et al. Aging, habitual exercise, and dynamic arterial compliance. Circulation. 2000;102:12701275.
  • 41
    Ferrier KE, Waddell TK, Gatzka CD, et al. Aerobic exercise training does not modify large-artery compliance in isolated systolic hypertension. Hypertension. 2001;38:222226.
  • 42
    Sierksma A, Lebrun CE, van Der Schouw YT, et al. Alcohol consumption in relation to aortic stiffness and aortic wave reflections: a cross-sectional study in healthy postmenopausal women. Arterioscler Thromb Vasc Biol. 2004;24:342348.
  • 43
    Avolio AP, Clyde KM, Beard TC, et al. Improved arterial distensibility in normotensive subjects on a low salt diet. Arteriosclerosis. 1986;6:166169.
  • 44
    Satoh N, Ogawa Y, Usui T, et al. Antiatherogenic effect of pioglitazone in type 2 diabetic patients irrespective of the responsiveness to its antidiabetic effect. Diabetes Care. 2003;26:24932499.
  • 45
    Kass DA, Shapiro EP, Kawaguchi M, et al. Improved arterial compliance by a novel advanced glycation end-product crosslink breaker. Circulation. 2001;104:14641470.
  • 46
    Vaitkevicius PV, Lane M, Spurgeon H, et al. A cross-link breaker has sustained effects on arterial and ventricular properties in older rhesus monkeys. Proc Natl Acad Sci U S A. 2001;98:11711175.
  • 47
    Garg JP, Elliott WJ, Folker A, et al. Resistant hypertension revisited: a comparison of two university-based cohorts. Am J Hypertens. 2005;18(5 pt 1):619626.
  • 48
    Moser M, Setaro J. Clinical practice. Resistant or difficult-to-control hypertension. N Engl J Med. 2006;355:385392.
  • 49
    The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:25602572.
  • 50
    Black HR, Elliott WJ, Neaton JD, et al. Baseline characteristics and early blood pressure control in the CONVINCE Trial. Hypertension. 2001;37:1218.